May12.org

CDC data show measles vaccines killed at least 2,657% more children than measles has since 1995. Our study found HUNDREDS of sudden deaths among infants and toddlers within days of MMR and MMRV vaccination. A vaccine should NEVER be deadlier than the disease.

Deaths Following MMR and MMRV Vaccination in the United States: zenodo.org/records/18671462

We found 84.4% of cancer patients taking ivermectin for 6 months declared their cancer was either COMPLETELY GONE, REGRESSED, or STOPPED SPREADING. It’s no surprise the CIA classified a 1950s study for over HALF A CENTURY showing anti-parasitics disrupt cancer growth.

Pfizer’s 4-DOSE Lyme disease vaccine is COMPLETE GARBAGE... the trial FAILED its primary endpoint. They claim 73% efficacy but the 95% confidence interval crashes down to 15.8% (>20% required to meet statistical success criteria). This means their trial proves nothing — yet they’re still rushing to FDA anyway to rake in BILLIONS. Criminal enterprise Pfizer at it again.

BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal 84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION. Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995. The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology. A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole. Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability. At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either: No evidence of disease (32.8%) Tumor regression (15.6%) or Cancer stabilization (36.1%) Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months. Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments. This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential. With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required. In the meantime, many cancer patients are exercising their right to try. @twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

The single LARGEST vaccine–dementia study ever conducted (n=13.3 MILLION) found that adult vaccines (flu, pneumococcal, shingles, tetanus, diphtheria, pertussis) increase risk of DEMENTIA (+38%) and ALZHEIMER’S (+50%) for a DECADE. The MORE doses, the HIGHER your dementia risk.

BREAKING: LANDMARK PEER-REVIEWED STUDY FINDS VACCINATION IS A MAJOR RISK FACTOR FOR AUTISM We found 79% of studies evaluating vaccines or their components (107 of 136) reported evidence consistent with a vaccine–autism link. After DECADES of censorship and denial, our 50-page analysis of more than 300 studies provides one of the most comprehensive syntheses to date on the possible causes of autism. The paper is now officially PEER-REVIEWED and PUBLISHED in the Journal of Independent Medicine. Autism’s rise is multifactorial—but routine childhood vaccination emerged as a MAJOR modifiable risk factor within the broader causal framework. We found potential determinants of new-onset autism before age 9 to include: 👵 Older parents (>35 years mother, >40 years father) 👶 Premature delivery (<37 weeks) 🧬 Common genetic variants 🧩 Siblings with autism 🔥 Maternal immune activation 💊 In utero drug exposure ☣️ Environmental toxicants 🦠 Gut–brain axis alterations 💉 Combination routine childhood vaccination Of 136 studies evaluating vaccines or their components: ➡️ 107 (79%) found evidence consistent with a vaccine–autism link ➡️ 29 reported “no association,” yet lacked unvaccinated controls and were riddled with major flaws ➡️ 12 studies comparing fully vaccinated vs. completely unvaccinated children found every time that the unvaccinated had superior overall health outcomes and substantially lower autism risk Biologic mechanisms converged on shared pathways—including immune dysregulation, mitochondrial dysfunction, and neuroinflammation—triggered by clustered and early-timed vaccination during critical windows of brain development. By evaluating all known risk factors side by side, this analysis uniquely clarifies the relative contribution of vaccination compared to genetic and environmental domains. No prior review has attempted this integrative scope without excluding positive vaccine-association studies or unvaccinated controls—an essential step in determining whether vaccines truly play a role in autism risk, and if so, how significant that role may be within the broader causal landscape. This publication represents a major breakthrough through the longstanding censorship imposed by the Bio-Pharmaceutical Complex on the issue of vaccination and autism. It also marks Dr. Andrew Wakefield’s first major return to the peer-reviewed scientific literature in years—after enduring decades of attacks from the vaccine cartel. CONCLUSION: The totality of evidence supports a multifactorial model of ASD in which genetic predisposition, neuroimmune biology, environmental toxicants, perinatal stressors, and iatrogenic exposures converge to produce the phenotype of a post-encephalitic state. Combination and early-timed routine childhood vaccination represents a significant modifiable risk factor for ASD within a broader multifactorial framework, supported by convergent mechanistic, clinical, and epidemiologic findings, and characterized by intensified use, the clustering of multiple doses during critical neurodevelopmental windows, and the lack of research on the cumulative safety of the full pediatric schedule. @McCulloughFund @P_McCulloughMD @DrAndyWakefield @Honest_Medicine @CPriceRogers @KirstinCosgrove @NathanMeadPhD @BreCraven_PA @MilaLRad